Johnson & Johnson Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Johnson & Johnson stocks.

Johnson & Johnson Stocks Recent News

Date Stock Title
May 21 JNJ Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
May 21 JNJ J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
May 20 JNJ Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis
May 20 JNJ Pulsed field ablation poised for fast adoption, analysts say
May 20 JNJ J&J posts latest Varipulse data while awaiting FDA review
May 19 JNJ Biopharma M&A surges year over year in Q1
May 18 JNJ Novo Nordisk, J&J lead R&D rankings in big pharma: report
May 18 JNJ Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18 JNJ Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO
May 17 JNJ Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
May 17 JNJ J&J-backed startup Rapport files for US IPO
May 17 JNJ J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
May 17 JNJ Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more
May 16 JNJ Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
May 16 JNJ Johnson & Johnson to Buy Proteologix For $850 Million in Cash
May 16 JNJ Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
May 16 JNJ Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors
May 16 JNJ Johnson & Johnson to buy dermatology-focused biotech Proteologix
May 16 JNJ UPDATE 1-Johnson & Johnson to acquire Proteologix for $850 million
May 16 JNJ Johnson & Johnson to acquire Proteologix for $850 million
Johnson & Johnson

Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015.
Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.

Browse All Tags